HM
Hardik Mukundbhai Prajapati
About Hardik Mukundbhai Prajapati
Data last updated:
Hardik Mukundbhai Prajapati is a Director at Accretion Pharmaceuticals Limited (since 2023), Director at Accretion Nutraveda Limited (since 2021) and Director at Accretion Nutraveda Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹92.16 Cr; the largest is Accretion Pharmaceuticals Limited at ₹57.47 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Accretion Pharmaceuticals Limited L21004GJ2023PLC146545 | Director | 29 Nov 2023 | 2023 | ₹57.47 Cr (FY 2025) | Active |
 Accretion Nutraveda Limited U24290GJ2021PLC121216 | Director | 16 Mar 2021 | 2021 | ₹16.01 Cr (FY 2025) | Active |
| Accretion Nutraveda Limited L24290GJ2021PLC121216 | Director | 16 Mar 2021 | 2021 | ₹16.01 Cr (FY 2025) | Active |
| Accresha Lifecare Private Limited U24100GJ2021PTC127506 | Director | 24 Nov 2021 | 2021 | ₹2.67 Cr (FY 2025) | Active |
Board colleagues of Hardik Mukundbhai Prajapati
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hardik Mukundbhai Prajapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hardik Mukundbhai Prajapati
Hardik Mukundbhai Prajapati currently holds 4 directorships: Accretion Pharmaceuticals Limited (Director, since 29 Nov 2023, revenue ₹57.47 Cr (FY 2025)); Accretion Nutraveda Limited (Director, since 16 Mar 2021, revenue ₹16.01 Cr (FY 2025)); Accretion Nutraveda Limited (Director, since 16 Mar 2021, revenue ₹16.01 Cr (FY 2025)); Accresha Lifecare Private Limited (Director, since 24 Nov 2021, revenue ₹2.67 Cr (FY 2025)).
Hardik Mukundbhai Prajapati was first appointed on 16 Mar 2021 as Director at Accretion Nutraveda Limited. The most recent appointment on record is 29 Nov 2023 at Accretion Pharmaceuticals Limited.
The 4 current companies of Hardik Mukundbhai Prajapati that report revenue have a combined latest revenue of ₹92.16 Cr: Accretion Pharmaceuticals Limited ₹57.47 Cr (FY 2025); Accretion Nutraveda Limited ₹16.01 Cr (FY 2025); Accretion Nutraveda Limited ₹16.01 Cr (FY 2025); Accresha Lifecare Private Limited ₹2.67 Cr (FY 2025).
The current boards of Hardik Mukundbhai Prajapati's companies include Chand Rameshbhai Kanabar (Accretion Pharmaceuticals Limited), Grishma A Shewale (Accretion Pharmaceuticals Limited), Harshad Nanubhai Rathod (Accretion Pharmaceuticals Limited), Harshad Nanubhai Rathod (Accretion Pharmaceuticals Limited), Mayur Popatlal Sojitra (Accretion Pharmaceuticals Limited), Nishtha Harivanshi Pamnani (Accretion Pharmaceuticals Limited), among others.